The association of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) K121Q gene polymorphism with the risk of type 2 diabetes mellitus in European, American, and African populations: a meta-analysis
Introduction: Several studies regarding the association of the ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) K121Q gene polymorphism with the risk of type 2 diabetes mellitus (T2DM) showed inconsistent results. This study aimed to investigate the association of ENPP1 K121Q gene polymorphism with T2DM risk using meta-analysis. The study was limited to the American, European, and African populations.
Methods: PubMed and Embase databases were searched for eligible publications. The following information was extracted from each study: name of first author, publication year, country of origin, sample size of cases and controls, and size of each allele. The combined odds ratios (ORs) and 95% confidence intervals (95% CIs) for the association between ENPP1 K121Q gene polymorphism and T2DM risk were assessed using random or fixed effect model. A comprehensive meta-analysis (CMA) 2.0 was used to analyze the data.
Results: Nineteen studies (17717 cases/28022 controls) on the association between ENPP1 K121Q gene polymorphism and T2DM risk were included in this meta-analysis. The results indicated that the ENPP1 K121Q gene polymorphism was associated with increased T2DM risk (Q vs. K genetic model, OR 95% CI = 1.11 [1.02–1.22], p = 0.014; QQ vs. KK + KQ, OR 95% CI = 1.14 [1.01–1.23], p = 0.039) and decreased T2DM risk (K vs. Q, OR 95% CI = 0.90 [0.82–1.00], p = 0.014; KK vs. KQ + QQ, OR 95% CI = 0.89 [0.80–0.98], p = 0.024).Conclusions: The results indicate that the ENPP1 K121Q gene polymorphism is associated with the risk of T2DM in the American, European, and African populations.
Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nature Genet. 2000;26:163-75. http://dx.doi.org/10.1038/79876.
DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Annals Internal Med. 1999;131(4):281-304. http://dx.doi.org/10.7326/0003-4819-131-4-199908170-00008.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27(1):S5-10. http://dx.doi.org/10.2337/diacare.27.2007.S5.
Keshavarz P, Inoue H, Sakamoto Y, Kunika K, Tanahashi T, Nakamura N, et al. No evidence for association of the ENPP1 (PC-1) K121Q variant with risk of type 2 diabetes in a Japanese population. J Hum Genet. 2006;51(6):559-66.
World Health Organization. Global report on diabetes. Geneva: World Health Organization; 2016.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53.
Lyssenko V, Laakso M. Genetic screening for the risk of type 2 diabetes. Diabetes Care. 2013;36(2):S120-6. http://dx.doi.org/10.2337/dcS13-2009.
Badaruddoza B, Barna B, Matharoo K, Bhanwer AJS. A case-control association study of K121Q (rs 1044498) and G/T (rs 1225572) variants in ENPP1 and TCF7L2 genes with type 2 diabetes mellitus in north Indian Punjabi population. Int J Diabetes Dev Ctries. 2015;35(4):546-53. http://dx.doi.org/10.1007/s13410-015-0337-9.
Yoon J, Wang H, Kim YC, Yoshimoto M, Abbasi S, Morse HC. Plasma cell alloantigen ENPP1 is expressed by a subset of human B Cells with potential regulatory functions. Immunol Cell Biol. 2016. http://dx.doi.org/10.1038/icb.2016.31.
Pan W, Chandalia M, Abate N. New insights into the role of ENPP1 in insulin resistance. J Metabonomics Metabolites. 2012;1(1):1000e103. DOI: 10.4172/2325-9736.1000e103.
Stolerman ES, Manning AK, McAteer JB, Dupuis J, Fox CS, Cupples LA, et al. Haplotype structure of the ENPP1 gene and nominal association of the K121Q missense single nucleotide polymorphism with glycemic traits in the Framingham Heart Study. Diabetes. 2008;57(7):1971-7. http://dx.doi.org/10.2337/db08-0266.
Maddux BA, Goldfine ID. Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor α-subunit. Diabetes. 2000;49(1):13-9
Costanzo BV, Trischitta V, Di Paola R, Spampinato D, Pizzuti A, Vigneri R, et al.The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121). Diabetes. 2001;50(4):831-6. http://dx.doi.org/10.2337/diabetes.50.4.831.
Rasmussen SK, Urhammer SA, Pizzuti A, Echwald SM, Ekstrøm CT, Hansen L, et al. The K121Q variant of the human PC-1 gene is not associated with insulin resistance or type 2 diabetes among Danish Caucasians. Diabetes. 2000;49(9):1608-11.
Abate N, Chandalia M, Satija P, Adams-Huet B, Grundy SM, Sandeep S, et al. ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes. Diabetes. 2005;54(4):1207-13. http://dx.doi.org/10.2337/diabetes.54.4.1207.
Meyre D, Bouatia-Naji N, Tounian A, Samson C, Lecoeur C, Vatin V, et al. Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nat Genet. 2005;37(8):863-7.
Chandalia M, Grundy SM, Adams-Huet B, Abate N. Ethnic differences in the frequency of ENPP1/PC1 121Q genetic variant in the Dallas Heart Study cohort. J Diabetes Complicat. 2007;21(3):143-8. http://dx.doi.org/10.1016/j.jdiacomp.2006.11.003.
Willer CJ, Bonnycastle LL, Conneely KN, Duren WL, Jackson AU, Scott LJ, et al. Screening of 134 single nucleotide polymorphisms (SNPs) previously associated with type 2 diabetes replicates association with 12 SNPs in nine genes. Diabetes. 2007;56(1):256-64.
Bouhaha R, Meyre D, Kamoun HA, Ennafaa H, Vaillant E, Sassi R, et al. Effect of ENPP1/PC-1-K121Q and PPARg-Pro12Ala polymorphisms on the genetic susceptibility to T2D in the Tunisian population. Diabetes Res Clin Pract. 2008;81(3):278-83.
Leitao CB, Nabinger GB, Krahe AL, Bolson PB, Gerchman F, Friedman R, et al. The role of K121Q ENPP1 polymorphism in diabetes mellitus and its complications. Braz J Med Biological Res. 2008;41(3):229-34. http://dx.doi.org/10.1590/S0100-879X2006005000202.
Pizzuti A, Frittitta L, Argiolas A, Baratta R, Goldfine ID, Bozzali M, et al. A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes. 1999;48(9):1881-4.
Gu HF, Almgren P, Lindholm E, Frittitta L, Pizzuti A, Trischitta V, et al. Association between the human glycoprotein PC-1 gene and elevated glucose and insulin levels in a paired-sibling analysis. Diabetes. 2000;49(9):1601-3.
Barroso I, Luan J, Middelberg RPS, Harding A, Franks PW, Jakes RW, et al. Candidate gene association study in type 2 diabetes indicates a role for genes involved in B-cell function as well as insulin action. PloS Biology. 2003;1(1):041-55.
Kubaszek A, Markkanen A, Eriksson JG, Forsen T, Osmond C, Barker DJP, et al. The association of the K121Q polymorphism of the plasma cell glycoprotein-1 gene with type 2 diabetes and hypertension depends on size at birth. J Clin Endocrinol Metab. 2004;89(5):2044-7. http://dx.doi.org/10.1210/jc.2003-031350.
Bacci S, Ludovico O, Prudente S, Zhang Y, Di Paola R, Mangiacotti D, et al. The K121Q polymorphism of the ENPP1/PC-1 gene is associated with insulin resistance/atherogenic phenotypes, including earlier onset of Type 2 diabetes and myocardial infarction. Diabetes. 2005;54(10):3021-5. http://dx.doi.org/10.2337/diabetes.54.10.3021.
Grarup N, Urhammer SA, Ek J, Albrechtsen A, Glümer C, Borch-Johnsen K, et al. Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects. Diabetologia. 2006;49(9):2097-104. http://dx.doi.org/10.1007/s00125-006-0353-x.
Bochenski J, Placha G, Wanic K, Malecki M, Sieradzki J, Warram JH, et al. New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals. Diabetes. 2006;55(9):2626-30. http://dx.doi.org/10.2337/db06-0191.
Lyon HN, Florez JC, Bersaglieri T, Saxena R, Winckler W, Almgren P, et al. Common variants in the ENPP1 gene are not reproducibly associated with diabetes or obesity. Diabetes. 2006;55(11):3180-4. http://dx.doi.org/10.2337/db06-0407.
Weedon MN, Shields B, Hitman G, Walker M, McCarthy MI, Hattersley AT, et al. No evidence of association of ENPP1 variants with type 2 diabetes or obesity in a study of 8,089 U.K. Caucasians. Diabetes. 2006;55(11):3175-9. http://dx.doi.org/10.2337/db06-0410.
Meyre D, Bouatia-Naji N, Vatin V, Veslot J, Samson C, Tichet J, et al. ENPP1 K121Q polymorphism and obesity, hyperglycaemia and type 2 diabetes in the prospective DESIR Study. Diabetologia. 2007;50(10):2090-6. http://dx.doi.org/10.1007/s00125-007-0787-9.
El Achhab Y, Meyre D, Bouatia-Naji N, Berraho M, Deweirder M, Vatin V, et al. Association of the ENPP1 K121Q polymorphism with type 2 diabetes and obesity in the Moroccan population. Diabetes Metab. 2009;35(1):37-42.
Yako YY, Madubedube JH, Kengne AP, Erasmus RT, Pillay TS, Matsha TE. Contribution of ENPP1, TCF7L2, and FTO polymorphisms to type 2 diabetes in mixed ancestry ethnic population of South Africa. Afri Health Sci. 2015;15(4):1149-60.
Thakkinstian A, D'Este C, Eisman J, Nguyen T, Attia J. Meta-analysis of molecular association studies: Vitamin D receptor gene polymorphisms and BMD as a case study. J Bone Miner Res. 2004;19(3):419-28. http://dx.doi.org/10.1359/JBMR.0301265.
Li YY. ENPP1 K121Q polymorphism and type 2 diabetes mellitus in the Chinese population: A meta-analysis including 11 855 subjects. Metabolism. 2012;61(5):625-33. http://dx.doi.org/10.1016/j.metabol.2011.10.002.
Jing C, Xueyao H, Linong J. Meta-analysis of the association studies between five candidate genes and type 2 diabetes in Chinese Han population. Endocrine. 2012;42(2):307-20. http://dx.doi.org/10.1007/s12020-012-9643-x.
Wang M, Peng C, Qu YL, Huang QY. Association and meta-analysis of ENPP1 K121Q with type 2 diabetes in Han Chinese. [Article in Chinese]. Yi Chuan. 2010;32(8):808-16.
Ruoqi W, Donghao Z, Bo X, Xiushan G, Ping Z, Bo W, et al. ENPP1/PC-1 gene K121Q polymorphism is associated with obesity in European adult populations: Evidence from a meta-analysis involving 24 324 subjects. Biomed Environ Sci. 2011;24(2):200-6. DOI: 10.3967/0895-3988.2011.02.015.
McAteer JB, Prudente S, Bacci S, Lyon HN, Hirschhorn JN, Trischitta V, et al. The ENPP1 K121Q polymorphism is associated with type 2 diabetes in European populations: evidence from an updated meta-analysis in 42,042 subjects. Diabetes. 2008;57(4):1125-30.
Tang S, Shen X, Tang H, Wang C, Wei W, Zhang Q, et al. Association of the ENPP1 K121Q polymorphism with susceptibility to type 2 diabetes in different populations: evidence based on 40 studies. Endocrine J. 2014;61(11):1093-103.
Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest. 2000;106(2):171-6. http://dx.doi.org/10.1172/JCI10583.
Reaven G. Insulin resistance, type 2 diabetes mellitus, and cardiovascular disease: The end of the beginning. Circulation. 2005;112(20):3030-2.
Kato K, Nishimasu H, Okudaira S, Mihara E, Ishitani R, Takagi J, et al. Crystal structure of Enpp1, an extracellular glycoprotein involved in bone mineralization and insulin signaling. PNAS. 2012;109(42):16876-81. http://dx.doi.org/10.1073/pnas.1208017109.
Maddux BA, Chang Y, Accili D, McGuinness OP, Youngren JF, Goldfine ID. Overexpression of the insulin receptor inhibitor PC-1/ENPP1 induces insulin resistance and hyperglycemia. Am J Physiol Endocrinol Metabolism. 2006;290(4):E746-9.
Sortica DA, Buffon MP, Souza BM, Nicoletto BB, Santer A, Assmann TS, et al. Association between the ENPP1 K121Q polymorphism and risk of diabetic kidney disease: A systematic review and meta-analysis. PLoS ONE. 2015;10(3):e0118416.
Copyright (c) 2016 Jonny Karunia Fajar
This work is licensed under a Creative Commons Attribution 4.0 International License.